Recode Health Ventures
95 3rd Street, 2nd Floor, San Francisco, CA, 94103, United States
Overview
Recode Health Ventures' founders' inventiveness in revolutionizing healthcare through the use of exponential technologies.
- Total investments
- 1
- Lead investments
- 0
- Investments · 12mo
- 0
- Active investors
- 0
Investment portfolio
- Sensible Biotechnologies
Participated · Seed · Apr 2023
Sensible Biotechnologies is developing a cell-based platform focused on the production and process aspects of mRNA for therapeutics and vaccines. The company intends its platform to enable cost-efficient manufacturing of mRNA and to integrate into biomanufacturing infrastructure and biosecurity frameworks. Led by CEO Miroslav Gasparek, Sensible emphasizes the mRNA aspect and process development needed for therapeutic and vaccine production. The company is based in Oxford, UK, and Bratislava, Slovakia. It plans to use newly raised funds to accelerate development of its cell-based manufacturing platform. No operating metrics were disclosed in the article.
Team
No current team members are available.